Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

JAK inhibitors show promise in treating difficult skin diseases.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.